SCHEMBL30278562

SCHEMBL30278562

[2H]C([2H])(c1cc(C)ccc1S(=O)(=O)O)C([2H])([2H])c1cc(C)ccc1S(=O)(=O)O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.36
GAA P10253 3/20 0.36
MEP1B Q16820 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
POLB P06746 2/20 0.36
MAPT P10636 2/20 0.36
KDM4E B2RXH2 1/20 0.36
RECQL P46063 1/20 0.36
CASP6 P55212 1/20 0.36
ELAVL1 Q15717 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MYC P01106 1/20 0.36
HSD17B10 Q99714 2/20 0.36
RAPGEF4 Q8WZA2 1/20 0.36
MPL P40238 1/20 0.35
AMY1A P0DUB6 1/20 0.34
HPGD P15428 2/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30439756 0.93 ALDH1A1 (0.35) ALDH1A1GAAMEP1BMEN1KMT2A
SCHEMBL30439901 0.93 MPL (0.36) ALDH1A1GAAMEP1BMEN1KMT2A
SCHEMBL14721068 0.90 ALDH1A1 (0.33) ALDH1A1GAAMEP1BMEN1KMT2A
SCHEMBL31544811 0.89 ALDH1A1 (0.36) ALDH1A1GAAMEP1BMEN1KMT2A
SCHEMBL31674524 0.89 MYC (0.35) ALDH1A1GAAMEP1BMEN1KMT2A
SCHEMBL20485 0.86 ALDH1A1 (0.35) ALDH1A1GAAMEP1BMEN1KMT2A
SCHEMBL1607815 0.85 RAPGEF4 (0.44) ALDH1A1GAAMEP1BMEN1KMT2A
SCHEMBL30823619 0.85 GAA (0.41) ALDH1A1GAAMEP1BMEN1KMT2A
SCHEMBL1180196 0.85 GAA (0.41) ALDH1A1GAAMEP1BMEN1KMT2A
SCHEMBL30716894 0.85 AMY1A (0.44) ALDH1A1GAAMEP1BMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12454536-B2 Deuterated 7-(3-(4-(2-([18F]fluoro)ethoxy)phenyl)propyl)-2-(furan-2-yl)-7H- pyrazolo [4,3-e][1,2,4]triazolo[1,5-C]pyrimidine-5-amine derivatives HELMHOLTZ-ZENTRUM DRESDEN-ROSSENDORF E.V. (DE) 2025-10-28 US disclosed
US-20230095104-A1 DEUTERATED 7-(3-(4-(2-([18F]FLUOR)ETHOXY)PHENYL)PROPYL)-2-(FURAN-2-YL)-7HPYRAZOLO [4,3-E][1,2,4]TRIAZOLO[1,5-C]PYRIMIDIN-5-AMINE DERIVATIVES HELMHOLTZ-ZENTRUM DRESDEN-ROSSENDORF E.V. (DE) 2023-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230095104-A1 DEUTERATED 7-(3-(4-(2-([18F]FLUOR)ETHOXY)PHENYL)PROPYL)-2-(FURAN-2-YL)-7HPYRAZOLO [4,3-E][1,2,4]TRIAZOLO[1,5-C]PYRIMIDIN-5-AMINE DERIVATIVES XDH, XPO4, FPR3 ALDH1A1 3778/4885GAA 2646/4885MEP1B 837/4885
US-12454536-B2 Deuterated 7-(3-(4-(2-([18F]fluoro)ethoxy)phenyl)propyl)-2-(furan-2-yl)-7H- pyrazolo [4,3-e][1,2,4]triazolo[1,5-C]pyrimidine-5-amine derivatives XDH, XPO4, XPO5 ALDH1A1 3561/4885GAA 3498/4885MEP1B 850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.